Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells

Acta Neuropathologica

Volumn 101, Issue 6, 2001, Pages 605-615

  Thomas, Christopher ^a   Ely, Greg ^c   James, C David ^c   Jenkins, Robert ^c   Kastan, Michael ^b   Jedlicka, Anne ^b   Burger, Peter ^b   Wharen, Robert ^a  

^a MAYO CLINIC   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Epidermal growth factor receptor; Glioblastoma; p53 gene; PTEN; Tumor cells

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EXTRACHROMOSOMAL DNA; LIGAND; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P21; PROTEIN P53;

ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CANCER GRADING; CARCINOGENICITY; CELL CYCLE G1 PHASE; CELL INTERACTION; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DOUBLE MINUTE CHROMOSOME; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENOTYPE; GLIOBLASTOMA; GLIOMA CELL; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; MITOSIS INHIBITION; MODEL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RADIATION RESPONSE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

BLOTTING, SOUTHERN; BRAIN NEOPLASMS; CYCLIN-DEPENDENT KINASES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENOTYPE; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION; MUTATION; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0034915394     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010000332     Document Type: Article

References (68)

1. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein
2. Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas
3. Molecular genetic alterations in radiation-induced astrocytomas
4. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas
5. Immunodetection of the ligand-activated receptor for epidermal growth factor
6. Growth factor modulation of p53-mediated growth arrest versus apoptosis
7. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway
8. The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme
9. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27(Kip1) into cyclin E/CDK2 complexes
10. Gene amplification in human gliomas
11. Progression as exemplified by human astrocytic tumors
12. PTEN mutations in gliomas and glioneuronal tumors
13. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification
14. 3′ end structure and rearrangements of EGFR gene in glioblastomas
15. Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line
16. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression
17. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G(1) growth arrest in glioma cells
18. The hallmarks of cancer
19. Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme
20. Cell transformation by the epidermal growth factor receptor and v-erbB
21. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification-associated over-expression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines
22. Hemizygous or homozygous deletion of the chromosomal region containing the p16(ink4a) gene is associated with amplification of the EGF receptor gene in glioblastomas
23. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice
24. The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling
25. Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts
26. Human glioblastomas with no alterations of the CDKn2a (P16(Ink4a), Mts 1) and CDK4 genes have frequent mutations of the retinoblastoma gene
27. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities
28. Frequent co-alterations of TP53, p16/CDKN2A, p14(ARF), PTEN tumor suppressor genes in human glioma cell lines
29. Tumor suppressor gene alterations in malignant gliomas: Histopathological associations and prognostic evaluation
30. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF
31. Primary and secondary glioblastomas: From concept to clinical diagnosis
32. Wild-type p53 is a cell cycle checkpoint determinant following irradiation
33. p53, the cellular gatekeeper for growth and division
34. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G(1) cell cycle arrest in human glioblastoma cells
35. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene
36. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas
37. A molecular genetic model of astrocytoma histopathology
38. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
39. PTEN: A tumour suppressor that functions as a phospholipid phosphatase
40. Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor
41. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase
42. Genetic alterations associated with the evolution and progression of astrocytic brain tumours
43. Lack of cyclin DCdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product
44. Molecular neuropathology of astrocytic brain tumors
45. The INK4a tumor suppressor gene product, p19(ARF), interacts with mdm2 and neutralizes mdm2s inhibition of p53
46. Regulation of G(1) progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway
47. Alterations of the TP53 gene in human gliomas
48. PTEN gene mutations are seen in high-grade but not in low-grade gliomas
49. Molecular pathogenesis of malignant gliomas
50. Control of the G1/S transition
51. A novel positive feedback loop mediated by the docking protein Gabl and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling
52. Patterns of epidermal growth factor receptor amplification in malignant gliomas
53. Linkage mapping of the human thromboxane A2 receptor (TBXA2R) to chromosome 19p13.3 using transcribed 3' untranslated DNA sequence polymorphisms
54. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor
55. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
56. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas
57. The autocrine loop of TGF-alpha/EGFR and brain tumors
58. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
59. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
60. Receptor protein-tyrosine kinases and their signal transduction pathways
61. Comprehensive allelotype and genetic analysis of 466 human nervous system tumors
62. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
63. EGF receptor
64. Structural alterations of the epidermal growth factor receptor gene in human gliomas
65. p53 gene mutations in pontine gliomas of juvenile onset
66. ARF promotes MDM2 degradation and stabilizes p53 - ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
67. Mutational analysis of the PTEN gene in gliomas: Molecular and pathological correlations